Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 4

Sponsor Class

OTHER 3NETWORK 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Plasma cell 4Myeloid 1Classical hematology 1

Conditions

Leukemia 12Breast Neoplasms 9Neoplastic Cells, Circulating 7Prostatic Neoplasms 5Leukemia, Myeloid, Acute 5Multiple Myeloma 4Lung Neoplasms 4Head and Neck Neoplasms 4Colorectal Neoplasms 4Wilms Tumor 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms, Plasma Cell 3Kidney Neoplasms 3Congenital Abnormalities 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Intraductal, Noninfiltrating 3Unspecified Adult Solid Tumor, Protocol Specific 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Ovarian Neoplasms 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms, Male 2Adenocarcinoma Of Esophagus 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1

Interventions

Dexamethasone 362Bortezomib 231Lenalidomide 200Cyclophosphamide 174Melphalan 154Calcium Dobesilate 107Peripheral Blood Stem Cell Transplantation 92fludarabine phosphate 84Thalidomide 81Filgrastim 71carfilzomib 68pomalidomide 66Granulocyte Colony-Stimulating Factor 60Mycophenolic Acid 59Busulfan 57daratumumab 54Whole-Body Irradiation 54Tacrolimus 51ixazomib 50Prednisone 50Cyclosporine 49fludarabine 46Antilymphocyte Serum 35Etoposide 30dexamethasone acetate 29Methotrexate 29plerixafor 27Radiotherapy 26Doxorubicin 26dexamethasone 21-phosphate 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Multiple Myeloma × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT00900055 2022-07-05

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

OHSU Knight Cancer Institute

Completed
213 enrolled
Classical hematologyMyeloidPlasma cell

Fanconi Anemia, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

NCT01155583 2020-11-16

Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Case Comprehensive Cancer Center

Phase 1/2 Completed
45 enrolled 20 charts
Plasma cell

Multiple Myeloma

NCT00899080 2017-05-17

Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide

Eastern Cooperative Oncology Group

Completed
33 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00616720 2011-05-16

Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma

Mayo Clinic

Phase 2 Completed
15 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡